• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

综合分析确定 为胶质母细胞瘤潜在的预后和免疫生物标志物。 (你提供的原文中“Identifies”后缺少具体内容)

Comprehensive Analysis Identifies as a Potential Prognostic and Immunological Biomarker in Glioblastoma.

作者信息

Chen Jianan, Wu Qiong, Berglund Anders E, Macaulay Robert J, Etame Arnold B

机构信息

Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.

Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.

出版信息

Cells. 2025 Jan 7;14(2):66. doi: 10.3390/cells14020066.

DOI:10.3390/cells14020066
PMID:39851494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11764009/
Abstract

Glioblastoma (GBM) is a highly aggressive brain tumor characterized by its ability to evade the immune system, hindering the efficacy of current immunotherapies. Recent research has highlighted the important role of immunosuppressive macrophages in the tumor microenvironment (TME) in driving this immune evasion. In this study, we are the first to identify as a key regulator of tumor-associated macrophage (TAM)-mediated immunosuppression in GBM. We found that a high expression is associated with poor patient outcomes and increased infiltration of immune cells, particularly macrophages. Functional analyses revealed 's critical involvement in immune-related pathways, including immune response activation, mononuclear cell differentiation, and the positive regulation of cytokine production. Additionally, single-cell RNA sequencing data demonstrated that macrophages with a high expression were associated with increased phagocytosis, immune suppression, and enhanced tumor growth. These findings suggest that could serve as both a prognostic marker and a therapeutic target for enhancing anti-tumor immunity in GBM.

摘要

胶质母细胞瘤(GBM)是一种极具侵袭性的脑肿瘤,其特点是能够逃避免疫系统,从而阻碍了当前免疫疗法的疗效。最近的研究强调了免疫抑制性巨噬细胞在肿瘤微环境(TME)中推动这种免疫逃逸的重要作用。在本研究中,我们首次确定[具体物质名称未给出]是胶质母细胞瘤中肿瘤相关巨噬细胞(TAM)介导的免疫抑制的关键调节因子。我们发现高[具体物质名称未给出]表达与患者预后不良以及免疫细胞尤其是巨噬细胞浸润增加有关。功能分析表明[具体物质名称未给出]在免疫相关途径中起关键作用,包括免疫反应激活、单核细胞分化以及细胞因子产生的正调控。此外,单细胞RNA测序数据表明,高[具体物质名称未给出]表达的巨噬细胞与吞噬作用增加、免疫抑制和肿瘤生长增强有关。这些发现表明,[具体物质名称未给出]既可以作为预后标志物,也可以作为增强胶质母细胞瘤抗肿瘤免疫力的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37a/11764009/4121fd1af584/cells-14-00066-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37a/11764009/3325727b2484/cells-14-00066-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37a/11764009/1a421576abcc/cells-14-00066-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37a/11764009/bed40f067d4e/cells-14-00066-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37a/11764009/fb9481e0b275/cells-14-00066-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37a/11764009/97680524bf92/cells-14-00066-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37a/11764009/4764eeabb7e5/cells-14-00066-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37a/11764009/4121fd1af584/cells-14-00066-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37a/11764009/3325727b2484/cells-14-00066-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37a/11764009/1a421576abcc/cells-14-00066-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37a/11764009/bed40f067d4e/cells-14-00066-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37a/11764009/fb9481e0b275/cells-14-00066-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37a/11764009/97680524bf92/cells-14-00066-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37a/11764009/4764eeabb7e5/cells-14-00066-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37a/11764009/4121fd1af584/cells-14-00066-g007.jpg

相似文献

1
Comprehensive Analysis Identifies as a Potential Prognostic and Immunological Biomarker in Glioblastoma.综合分析确定 为胶质母细胞瘤潜在的预后和免疫生物标志物。 (你提供的原文中“Identifies”后缺少具体内容)
Cells. 2025 Jan 7;14(2):66. doi: 10.3390/cells14020066.
2
Single-cell and spatial analyses reveal the effect of VSIG4S100A10TAMs on the immunosuppression of glioblastoma and anti-PD-1 immunotherapy.单细胞和空间分析揭示了VSIG4⁺S100A10⁺肿瘤相关巨噬细胞对胶质母细胞瘤免疫抑制和抗PD-1免疫治疗的影响。
Int J Biol Macromol. 2025 May;308(Pt 3):142415. doi: 10.1016/j.ijbiomac.2025.142415. Epub 2025 Mar 22.
3
The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with Glioblastoma.FKBP51s 剪接异构体预测胶质母细胞瘤患者预后不良。
Cancer Res Commun. 2024 May 16;4(5):1296-1306. doi: 10.1158/2767-9764.CRC-24-0083.
4
IL-19 as a promising theranostic target to reprogram the glioblastoma immunosuppressive microenvironment.白细胞介素-19作为一种有前景的诊疗靶点,可重编程胶质母细胞瘤免疫抑制微环境。
J Biomed Sci. 2025 Mar 8;32(1):34. doi: 10.1186/s12929-025-01126-w.
5
Exploring the prognostic value of BRMS1 + microglia based on single-cell anoikis regulator patterns in the immunologic microenvironment of GBM.基于单细胞失巢凋亡调节因子模式探索BRMS1 +小胶质细胞在胶质母细胞瘤免疫微环境中的预后价值。
J Neurooncol. 2024 Oct;170(1):101-117. doi: 10.1007/s11060-024-04781-5. Epub 2024 Aug 15.
6
Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.单细胞和患者队列的表达谱分析鉴定出胶质母细胞瘤中的多种免疫抑制途径和改变的 NK 细胞表型。
Clin Exp Immunol. 2020 Apr;200(1):33-44. doi: 10.1111/cei.13403. Epub 2019 Dec 16.
7
The N-Methyladenosine-Modified Pseudogene HSPA7 Correlates With the Tumor Microenvironment and Predicts the Response to Immune Checkpoint Therapy in Glioblastoma.N6-甲基腺苷修饰的假基因 HSPA7 与肿瘤微环境相关,并预测胶质母细胞瘤对免疫检查点治疗的反应。
Front Immunol. 2021 Jul 20;12:653711. doi: 10.3389/fimmu.2021.653711. eCollection 2021.
8
S100A11 is a potential prognostic biomarker and correlated with tumor immunosuppressive microenvironment in glioma.S100A11是一种潜在的预后生物标志物,与胶质瘤中的肿瘤免疫抑制微环境相关。
Medicine (Baltimore). 2024 Dec 20;103(51):e40701. doi: 10.1097/MD.0000000000040701.
9
Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.系统识别、开发和验证涉及胶质母细胞瘤肿瘤免疫微环境的预后生物标志物。
J Cell Physiol. 2021 Jan;236(1):507-522. doi: 10.1002/jcp.29878. Epub 2020 Jun 22.
10
Necroptosis-based glioblastoma prognostic subtypes: implications for TME remodeling and therapy response.基于坏死性细胞凋亡的胶质母细胞瘤预后亚型:对 TME 重塑和治疗反应的影响。
Ann Med. 2024 Dec;56(1):2405079. doi: 10.1080/07853890.2024.2405079. Epub 2024 Oct 10.

引用本文的文献

1
Identification of an Immune-Related Gene Signature for Prognostic Prediction in Glioblastoma: Insights from Integrated Bulk and Single-Cell RNA Sequencing.胶质母细胞瘤预后预测的免疫相关基因特征鉴定:来自综合批量和单细胞RNA测序的见解
Cancers (Basel). 2025 May 28;17(11):1799. doi: 10.3390/cancers17111799.

本文引用的文献

1
Immunoediting Dynamics in Glioblastoma: Implications for Immunotherapy Approaches.免疫编辑在胶质母细胞瘤中的动态变化:对免疫治疗方法的启示。
Cancer Control. 2024 Jan-Dec;31:10732748241290067. doi: 10.1177/10732748241290067.
2
From promise to progress: the dynamic landscape of glioblastoma immunotherapy.从承诺到进展:胶质母细胞瘤免疫治疗的动态景观。
Drug Discov Today. 2024 Nov;29(11):104188. doi: 10.1016/j.drudis.2024.104188. Epub 2024 Sep 20.
3
Macrophage-mediated myelin recycling fuels brain cancer malignancy.巨噬细胞介导的髓磷脂再循环促进脑癌恶性进展。
Cell. 2024 Sep 19;187(19):5336-5356.e30. doi: 10.1016/j.cell.2024.07.030. Epub 2024 Aug 12.
4
The Role of Mesenchymal Reprogramming in Malignant Clonal Evolution and Intra-Tumoral Heterogeneity in Glioblastoma.间质重编程在胶质母细胞瘤恶性克隆进化和肿瘤内异质性中的作用。
Cells. 2024 May 30;13(11):942. doi: 10.3390/cells13110942.
5
THEMIS2 Impairs Antitumor Activity of NK Cells by Suppressing Activating NK Receptor Signaling.THEMIS2 通过抑制激活的 NK 受体信号来削弱 NK 细胞的抗肿瘤活性。
J Immunol. 2024 Jun 1;212(11):1819-1828. doi: 10.4049/jimmunol.2300771.
6
Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors.克服冷肿瘤:免疫检查点抑制剂的联合策略。
Front Immunol. 2024 Mar 13;15:1344272. doi: 10.3389/fimmu.2024.1344272. eCollection 2024.
7
Immune Escape in Glioblastoma: Mechanisms of Action and Implications for Immune Checkpoint Inhibitors and CAR T-Cell Therapy.胶质母细胞瘤中的免疫逃逸:作用机制及其对免疫检查点抑制剂和嵌合抗原受体T细胞疗法的影响
Biology (Basel). 2023 Dec 15;12(12):1528. doi: 10.3390/biology12121528.
8
LILRB3 suppresses immunity in glioma and is associated with poor prognosis.LILRB3抑制胶质瘤中的免疫反应,并与不良预后相关。
Clin Transl Med. 2023 Oct;13(10):e1396. doi: 10.1002/ctm2.1396.
9
SIGLEC9 tips the myeloid balance in glioblastoma.信号淋巴细胞激活分子9(SIGLEC9)改变胶质母细胞瘤中的髓系平衡。
Nat Cancer. 2023 Sep;4(9):1217-1219. doi: 10.1038/s43018-023-00603-1.
10
Dictionary learning for integrative, multimodal and scalable single-cell analysis.基于字典学习的综合、多模态和可扩展的单细胞分析。
Nat Biotechnol. 2024 Feb;42(2):293-304. doi: 10.1038/s41587-023-01767-y. Epub 2023 May 25.